Skip to Main Content

Author Details

Noah Federman
University of California los angeles
2001
94
27
PMIDPaper TitleJournal TitlePublished Year
36529089REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients.Nutrition2023
37664028A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma.Front Oncol2023
37549914Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2023
37772566From Mendel to Gene Therapy.Anticancer Res2023
37325672Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report.Front Immunol2023
37292676The landscape of drug sensitivity and resistance in sarcoma.bioRxiv2023
37053536Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy.JCO Precis Oncol2023
37283290A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis.Pediatr Blood Cancer2023
37101365Maternal migraine and risk of pediatric cancers.Pediatr Blood Cancer2023
37333052Fibroblast Activation Protein Expression in Sarcomas.Sarcoma2023
36884323Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.N Engl J Med2023
36434977Maternal anemia and childhood cancer: a population-based case-control study in Denmark.Cancer Epidemiol2023
36765863SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.Cancers (Basel)2023
36600459Maternal anemia and the risk of childhood cancer: A population-based cohort study in Taiwan.Pediatr Blood Cancer2023
35171675Personalized chordoma organoids for drug discovery studies.Sci Adv2022
35486030Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations.Adv Sci (Weinh)2022
36068332Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition.NPJ Precis Oncol2022
36088507Maternal diabetes and childhood cancer risks in offspring: two population-based studies.Br J Cancer2022
35274131Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.Pediatrics2022
34966942Cohort study of familial viral hepatitis and risks of paediatric cancers.Int J Epidemiol2022
35201681Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer.Am J Manag Care2022
35201680Diagnosis and management of TRK fusion cancer.Am J Manag Care2022
33027233What's New in Pediatric Orthopaedic Tumor Surgery.J Pediatr Orthop2021
33844938The Role of Social Media in Providing Support from Friends for Adolescent and Young Adult (AYA) Patients and Survivors of Sarcoma: Perspectives of AYA, Parents, and Providers.J Adolesc Young Adult Oncol2021
34115928T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.Mol Oncol2021
32398945Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.Sarcoma2020
34220409Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies.Adv Funct Mater2020
31675134Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.Genes Chromosomes Cancer2020
32079720A Case of a 15-Month-Old With Periorbital Edema and Severe Anemia.Pediatrics2020
32105622Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.Lancet Oncol2020
33063147[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial.EJNMMI Res2020
32364426Spina bifida and pediatric cancers.Pediatr Hematol Oncol2020
32282650Primary Renal Ewing Sarcoma in Children and Young Adults.J Pediatr Hematol Oncol2020
30592640TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.J Clin Oncol2019
31687646Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.JBMR Plus2019
30255546Fetal programming and Wilms tumor.Pediatr Blood Cancer2019
31469968Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer.Expert Rev Clin Pharmacol2019
31197971Is polycystic kidney disease associated with malignancy in children?Mol Genet Genomic Med2019
31274668A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy.J Pediatr Hematol Oncol2019
30913092Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.Am J Clin Oncol2019
30882352A Mobile-Based Mindfulness and Social Support Program for Adolescents and Young Adults With Sarcoma: Development and Pilot Testing.JMIR Mhealth Uhealth2019
29350467Alveolar soft part sarcoma in children and young adults: A report of 69 cases.Pediatr Blood Cancer2018
30204247The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.Cancer2018
29529643Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?Clin Orthop Relat Res2018
29664796Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.Am J Clin Oncol2018
29606586Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.Lancet Oncol2018
29466156Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.N Engl J Med2018
29763624The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.Cancer Cell2018
27577987Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation.Pediatr Blood Cancer2017
30613825Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial.JCO Precis Oncol2017
  • 1 - 50 of 94

Recommended Authors

Ohio State University College of Medicine/Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 2
University at Buffalo Jacobs School of Medicine and Biomedical Sciences
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 7
University of Oklahoma Health Sciences Center
Career Start Year 2005
Number of shared co-authors 0
University College London, Cancer Institute
Career Start Year 2003
Number of shared co-authors 5
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 3
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 4
British Columbia Children's Hospital, The University of British Columbia
Career Start Year 1998
Number of shared co-authors 3
Royal Manchester Children's Hospital
Career Start Year 1997
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 5
Hasbro Children's Hospital, Brown University.
Career Start Year 1997
Number of shared co-authors 1
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 8
Centre Leon Berard & Universite Claude Bernard
Career Start Year 1996
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 10
Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 1995
Number of shared co-authors 6
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 8
Mount Sinai Hospital
Career Start Year 1994
Number of shared co-authors 3
Children's Hospitals and Clinics of Minnesota
Career Start Year 1993
Number of shared co-authors 2
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 2
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 5
McGill University
Career Start Year 1990
Number of shared co-authors 1
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 8
Ruth Rappaport Children's Hospital
Career Start Year 1988
Number of shared co-authors 0
Universite Paris-Saclay
Career Start Year 1988
Number of shared co-authors 4
Clinical Trials Unit
Career Start Year 1983
Number of shared co-authors 3
Boston Children's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 10
Children's Cancer Therapy Development Institute
Career Start Year 1980
Number of shared co-authors 5
Keck School of Medicine, University of Southern California
Career Start Year 1977
Number of shared co-authors 4

Collaborators

University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 20
University of California-Los Angeles
Co-authored papers 18
University of California-Los Angeles
Co-authored papers 16
University of California-Los Angeles
Co-authored papers 14
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 13
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 8
Co-authored papers 7
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 7
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 5
St Jude Children's Research Hospital
Co-authored papers 5
university of california los angeles
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Fielding School of Public Health, University of California los angeles
Co-authored papers 4
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 4
Co-authored papers 4
University of California
Co-authored papers 3
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
Co-authored papers 3
University of California-Los Angeles
Co-authored papers 2
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
university of california los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
Georgetown University Medical Center, Georgetown University
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Co-authored papers 2
University of California los angeles
Co-authored papers 2